Navigation Links
Herpes infections: Natural killer cells activate hematopoiesis
Date:5/16/2013

Infections can trigger hematopoiesis at sites outside the bone marrow in the liver, the spleen or the skin.Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich now show that a specific type of immune cell facilitates such "extra medullary" formation of blood cells.

Balanced hematopoiesis is essential for the function of the immune system. During fetal development, hematopoiesis takes place mainly in the liver and the spleen. Later the process is delegated to the bone marrow, and this tissue normally serves as the sole source of blood cells for the rest of one's lifetime. However, certain infections can reactivate hematopoiesis at sites other than the bone marrow, a process which is referred to as "extramedullary" hematopoiesis. One of the best known inducers is the so-called cytomegalovirus (CMV), a member of the herpesvirus family, which is widespread in human populations worldwide, and can lead to serious illness in individuals with immature or otherwise compromised immune systems.

An international team led by Professor Ulrich Koszinowski at LMU's Max von Pettenkofer-Institute has now examined how this virus activates hematopoiesis in tissues other than the bone marrow. "Herpesviruses are highly species-specific," explains Dr. Stefan Jordan, the lead author on the new paper. "So, in order to study the phenomenon of extramedullary hematopoiesis in an animal model, we were forced to turn to the mouse virus." The murine CMV induces extramedullary hematopoiesis principally in the spleen.

Killing of infected cells paves the way

The new findings reveal a hitherto unsuspected link between natural killer (NK) cells and hematopoiesis. NK cells play an important role in combating CMV infections, because they are the immune system's first line of defense against the virus. In the first place, they are able to recognize and eliminate CMV-infected cells and, secondly, they synthesize and secrete signal molecules that mobilize other types of immune cells to mount a concerted attack on the pathogen.

"The decisive factor that leads to hematopoiesis at otherwise dormant sites is the ability of NK cells to find and destroy virus-infected cells," says Jordan. Extramedullary hematopoiesis is actually initiated by the inflammatory reaction that occurs as an early response to infection with CMV. But when the virus can replicate and spread to other cells, the pathogen suppresses the process. "The development of extramedullary hematopoiesis in the spleen is dependent on the capacity of NK cells to prevent virus spread by effectively eliminating infected cells," Jordan explains.

Extramedullary hematopoiesis itself thus appears to be an antiviral reaction. This in turn has obvious implications for the development of novel therapies. Thus, targeted stimulation of the mechanism that triggers the process could help to fight and resolve viral infections. Conversely, there are situations in which the immune system overshoots, and the spleen becomes so enlarged that it has to be surgically removed. "In this context, it would be particularly useful to understand how CMV suppresses extramedullary hematopoiesis then one might be able to exploit the mechanism to prevent rupture of the splenic capsule and life-threatening internal bleedings," Jordan concludes.


'/>"/>

Contact: Luise Dirscherl
dirscherl@lmu.de
49-892-180-2706
Ludwig-Maximilians-Universitt Mnchen
Source:Eurekalert

Related biology news :

1. How and why herpes viruses reactivate to cause disease
2. Princeton researchers identify unexpected bottleneck in the spread of herpes simplex virus
3. Novel treatment approach for bladder pain using a herpes simplex virus vector reported
4. Einstein study reveals new approach for stopping herpes infections
5. How herpesvirus invades nervous system
6. Biology professor secures grant to save West Virginias primary natural history collection
7. Validity CTO to Present Natural ID Solutions for Improving Mobile Risk Management and User Experience at NFC Solutions Summit 2012
8. Honoring the fundamental role of microbes in the natural history of our planet
9. Resveratrol may be a natural exercise performance enhancer: U of A medical research
10. Naturally adhesive
11. No matter the drilling method, natural gas is a much-needed tool to battle global warming
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
Breaking Biology Technology: